Literature DB >> 16715609

Aprotinin in the management of coagulopathy associated with amniotic fluid embolus.

Jeffrey Stroup1, Davin Haraway, J Martin Beal.   

Abstract

Amniotic fluid embolus, also known as anaphylactoid syndrome of pregnancy is a rare complication of pregnancy. When it occurs, the maternal mortality rate may be as high as 86%, and in survivors, the morbidity rate may be just as high. Hallmark clinical features include maternal cardiovascular collapse with disseminated intravascular coagulation, and fetal distress. Management centers on strategies to improve oxygenation, support circulation, and correct the coagulopathy. We report the case of a patient who developed amniotic fluid embolus and was effectively managed with aprotinin to control the coagulopathy associated with this devastating complication of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715609     DOI: 10.1592/phco.26.5.689

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

Review 1.  Amniotic fluid embolism: an evidence-based review.

Authors:  Agustín Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2009-11       Impact factor: 8.661

Review 2.  Clinical review: Special populations--critical illness and pregnancy.

Authors:  Patrick J Neligan; John G Laffey
Journal:  Crit Care       Date:  2011-08-12       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.